Bearish flow noted in Capricor Therapeutics (CAPR) with 7,802 puts trading, or 13x expected. Most active are Sep-25 7.5 puts and Jun-25 12.5 puts, with total volume in those strikes near 6,100 contracts. The Put/Call Ratio is 4.27, while ATM IV is up nearly 17 points on the day. Earnings are expected on August 7th.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor weakness attributed to FDA letter on advisory meeting
- Capricor Therapeutics’ Strategic Advances and Market Positioning Boost Buy Rating for Deramiocel in DMD Treatment
- H.C. Wainwright says Capricor path to approval ‘sharpens’ with inspection done
- Promising Regulatory Progress and Upcoming Milestones Support Buy Rating for Capricor Therapeutics
- Capricor says FDA inspection brought Form 483 with several observations